GenBio
GenBio is a US-based, FDA-registered in vitro diagnostics manufacturer (founded 1994, San Diego) that develops and sells EIA serology kits under the ImmunoDOT, ImmunoWELL, and ImmunoFLOW brands to clinical, reference, and government laboratories for infectious and autoimmune disease testing. It operates as a subsidiary of Eurobio Scientific Group.
- Company typePrivate
- Founded1994
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What GenBio does
GenBio (legal entity GenDx LLC, doing business as GenBio) is a privately held, fully integrated in vitro diagnostics company founded in 1994 and headquartered in San Diego, California. It develops, manufactures, and markets serology test kits that detect antibodies associated with specific infectious and autoimmune diseases, and operates as a subsidiary of the France-based Eurobio Scientific Group.
GenBio's commercial offering is built around three proprietary immunoassay platforms: ImmunoDOT, a rapid dotblot EIA that simultaneously tests up to six analytes from a single patient specimen with results in roughly 30 minutes and a proprietary color-development system; ImmunoWELL, a microtiter-plate ELISA format designed for centralized, high-throughput reference-laboratory batch processing; and ImmunoFLOW, a cassette-based immunoassay that produces visually interpreted results without specialized equipment, including the company's CE-marked Mycoplasma pneumoniae IgM cassette. The menu targets infectious-disease serology (Coxiella/Q fever, Leptospira, Rickettsia, Mycoplasma, Salmonella) and autoimmune testing (antinuclear antibodies for connective tissue diseases including lupus erythematosus), with the Mycoplasma franchise positioned around use of the gold-standard complement-fixation antigen.
GenBio's business model is a conventional B2B diagnostics manufacturer model: products are sold direct to clinical laboratories, hospital and group-practice labs, reference and centralized laboratories, and government testing facilities, with ordering handled via direct contact (phone and inquiry form) and no disclosed public pricing. The company operates under ISO 13485:2016 quality certification and US FDA Manufacturer registration, and selectively holds CE marks on European-targeted products. Its go-to-market is materially augmented by Eurobio Scientific Group's established international commercial infrastructure and adjacent molecular-diagnostics / HLA-typing portfolio through its GenDx affiliates, giving the small GenBio team (1-10 employees) a global sales footprint disproportionate to its headcount.
GenBio firmographics
Firmographics- Name
- GenBio
- Legal name
- GenDx LLC dba GenBio
- Website
- https://genbio.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- GenBio is a US-based, FDA-registered in vitro diagnostics manufacturer (founded 1994, San Diego) that develops and sells EIA serology kits under the ImmunoDOT, ImmunoWELL, and ImmunoFLOW brands to clinical, reference, and government laboratories for infectious and autoimmune disease testing. It operates as a subsidiary of Eurobio Scientific Group.
- Ownership category
- akta.pro rank
GenBio industry classification
Industry- Product category
- In Vitro Diagnostics — Serology Test Kits
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
- akta.pro secondary industry
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
Keywords
Where GenBio is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
GenBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others
Distribution channels1 record
Marketing channels2 records
GenBio product offering
Product offeringCore offering
GenBio is a fully integrated in vitro diagnostics company that designs, develops, manufactures, and distributes serology test kits for detecting antibodies to infectious and autoimmune diseases. Its three proprietary platforms — ImmunoDOT (rapid multiplexed dipstick EIA), ImmunoWELL (microtiter ELISA for high-throughput labs), and ImmunoFLOW (equipment-free cassette immunoassay) — serve clinical laboratories, hospitals, clinics, and reference laboratories globally as a subsidiary of the Eurobio Scientific Group.
Product overview
GenBio is a fully integrated diagnostics company specializing in infectious disease and autoimmune testing. The company develops, manufactures, and markets serology products under three main product lines: ImmunoDOT (a proprietary dotblot EIA for rapid, multiplexed testing), ImmunoWELL (a microtiter ELISA platform for high-throughput batch processing), and ImmunoFLOW (a rapid cassette immunoassay for point-of-care settings). These products detect antibodies to infectious disease targets (Coxiella, Leptospira, Mycoplasma, Rickettsia, Salmonella) and autoimmune disease targets (Connective Tissue Disease/Lupus Erythematosus). The three platforms serve different laboratory settings: ImmunoDOT and ImmunoFLOW offer rapid, user-friendly testing with no specialized equipment, while ImmunoWELL supports high-throughput centralized laboratory operations.
Differentiator
Problem solved
Functional benefit
Brands
- ImmunoDOT: User-friendly, rapid dipstick Enzyme Immunoassay (EIA) for simultaneous testing of multiple parameters from a single patient specimen
- ImmunoFLOW
- ImmunoWELL
Products and services
- ImmunoDOT User-friendly, rapid dipstick Enzyme Immunoassay (EIA) using a nitrocellulose membrane dot format that enables simultaneous testing of up to six parameters from a single patient specimen, with results in 30 minutes. Designed for clinical laboratories, hospitals, clinics, and group practice laboratories that need rapid patient testing rather than batch processing.
- ImmunoWELL High-throughput microtiter plate Enzyme Immunoassay (ELISA) system designed for centralized laboratories. Supports batch processing of single-analyte diagnostic tests using standard microtiter readers, washers, and sample handling systems.
- ImmunoFLOW Rapid, visually interpreted immunoassay cassette test that detects IgM antibodies to Mycoplasma pneumoniae complement-fixing antigen using a nitrocellulose paper matrix with gold particle detection. Delivers results without specialized equipment, suited to point-of-care and rapid testing environments.
Companies that use GenBio
Customer profileSegments4 records
Ideal customer profiles3 records
GenBio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
GenBio partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
GenBio competitors and assessment
Company assessmentBroad incumbents
- Bio-Rad Laboratories: Large diversified life science and diagnostics company with extensive IVD and quality-control serology offerings; competes with GenBio at the high-throughput reference-lab tier but as part of a much broader portfolio spanning research, clinical, and food safety markets.
- DiaSorin: Global specialty IVD company with strong infectious disease and immunoassay franchises (LIAISON platform); its serology and CLIA menu competes with GenBio's ImmunoWELL line in mid-to-large hospital and reference labs.
Others
- Eurobio Scientific: Public parent company of GenBio; while not a direct competitor, Eurobio's own specialty IVD products (molecular, HLA typing) flow through GenBio's US footprint, making it both a parent and a portfolio-comparable peer in the European specialty IVD category.
Direct peers
- Trinity Biotech: Public IVD company with a portfolio spanning infectious disease serology (including Lyme, syphilis) and clinical chemistry; competes with GenBio in small-to-mid lab serology formats, particularly in the ImmunoDOT-like rapid strip category.
- EUROIMMUN (Revvity): A leading autoimmune and infectious disease serology manufacturer now part of Revvity (formerly PerkinElmer); EUROIMMUN offers ELISA, immunofluorescence, and blot-based platforms overlapping GenBio's product modalities, and competes in the same ANA/connective tissue disease menu.
- Inova Diagnostics (Werfen): Specialty autoimmune diagnostics manufacturer within the Werfen group; offers ELISA and bead-based assays for ANA and connective tissue disease that directly compete with GenBio's autoimmune serology menu.
- MBL International (Medical & Biological Laboratories): Japanese-headquartered specialty manufacturer of autoimmune and infectious disease diagnostic kits; directly comparable product format (ELISA, immunoblot) and customer overlap with GenBio's clinical laboratory and hospital segments.
- Meridian Bioscience (Revvity): IVD manufacturer focused on infectious disease diagnostics including immunoassays and rapid tests; its gastrointestinal and respiratory serology products overlap GenBio's infectious disease menu and target similar laboratory customers.
- ZEUS Scientific: US-based IVD manufacturer specializing in serology assays for infectious and autoimmune diseases, with a multi-format product portfolio closely paralleling GenBio's ImmunoDOT/ImmunoWELL/ImmunoFLOW strategy. Both serve clinical and reference laboratories with antibody-detection kits for similar disease targets.
Emerging players
- Oxford Immunotec (Revvity/PerkinElmer): Specialty infectious disease diagnostics company, originally focused on T-cell-based TB testing, now part of Revvity; relevant as a serial-acquirer profile of how niche IVD franchises are absorbed into larger specialty diagnostics groups — a comparable exit-path signal.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
GenBio social profiles
Digital presenceGenBio compliance and trust
Trust signalCompliance4 records
GenBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenBio leadership team
Management profileNumber of profiles
Profiles1 record
GenBio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenBio
What does GenBio do?
GenBio is a fully integrated in vitro diagnostics company that designs, develops, manufactures, and distributes serology test kits for detecting antibodies to infectious and autoimmune diseases. Its three proprietary platforms — ImmunoDOT (rapid multiplexed dipstick EIA), ImmunoWELL (microtiter ELISA for high-throughput labs), and ImmunoFLOW (equipment-free cassette immunoassay) — serve clinical laboratories, hospitals, clinics, and reference laboratories globally as a subsidiary of the Eurobio Scientific Group.
Is GenBio a public or private company?
GenBio is a private company. It is classified as corporate owned and is currently operating.
When was GenBio founded?
GenBio was founded in 1994. It employs 1 to 10 people.
Where is GenBio based?
GenBio is headquartered in San Diego, United States, in the North America region.
Who are GenBio's main competitors?
Broad incumbents on record are Bio-Rad Laboratories and DiaSorin. Eurobio Scientific is listed as an others. Direct peers are Trinity Biotech, EUROIMMUN (Revvity), Inova Diagnostics (Werfen), MBL International (Medical & Biological Laboratories), Meridian Bioscience (Revvity) and ZEUS Scientific. Oxford Immunotec (Revvity/PerkinElmer) is listed as an emerging player.
Does GenBio have an API?
No public API is recorded for GenBio.
What industry is GenBio in?
GenBio's product category is In Vitro Diagnostics — Serology Test Kits. Its primary akta.pro industry code is HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.